The incidence of primary pulmonary infections for most of the major biothreats is extremely low. Therefore, we will not be able to rely on testing new therapeutics and vaccines during """"""""natural"""""""" outbreaks as is commonly done for many more common infections. Further, as is the case with the human immunodeficiency virus, direct challenges with the biothreats in normal human populations is unlikely to be a viable alternative. Because of these issues we will need to rely on animal models much more than usual for understanding the basic pathophysiology of the disease as well as determining the efficacy of new therapeutics and vaccines. The development of well-characterized nonhuman primate models that recapitulate human disease is extremely important to NIH's mission of biodefense. The combination of UNM and LRRI brings together significant expertise that makes this core very unique in its capabilities. The PI of this program project, Dr. Lyons, at UNMHSC has handled the biothreats for over 2 years and developed all of the protocols and safety requirements for appropriate handling and management of the select agents including Bacillus anthracis and virulent Francisella tularensis. This proposal intends to use both mice and nonhuman primates to identify mechanisms of virulence and host protection. It will combine the strengths in UNMHSC Microbiology with the aerosol and primate expertise of Lovelace Respiratory Research Institute. Specifically the non-human primate core will: 1) Develop reproducible aerosol models in non-human primates for virulent Francisella tularensis and Bacillus anthracis. 2) Perform aerosol challenges, necropsy and tissue harvesting for the aims in Project 1 and 3.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI056295-04
Application #
7632085
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2008-07-01
Budget End
2009-06-30
Support Year
4
Fiscal Year
2008
Total Cost
$1,391,614
Indirect Cost
Name
University of New Mexico
Department
Type
DUNS #
868853094
City
Albuquerque
State
NM
Country
United States
Zip Code
87131
Hutt, Julie A; Lovchik, Julie A; Drysdale, Melissa et al. (2014) Lethal factor, but not edema factor, is required to cause fatal anthrax in cynomolgus macaques after pulmonary spore challenge. Am J Pathol 184:3205-16
Lovchik, Julie A; Drysdale, Melissa; Koehler, Theresa M et al. (2012) Expression of either lethal toxin or edema toxin by Bacillus anthracis is sufficient for virulence in a rabbit model of inhalational anthrax. Infect Immun 80:2414-25
Mara-Koosham, Gopi; Hutt, Julie A; Lyons, C Rick et al. (2011) Antibodies contribute to effective vaccination against respiratory infection by type A Francisella tularensis strains. Infect Immun 79:1770-8
Hansen, Spencer J; Rushton, John; Dekonenko, Alexander et al. (2011) Cowpox virus inhibits human dendritic cell immune function by nonlethal, nonproductive infection. Virology 412:411-25
Chand, Hitendra S; Schuyler, Mark; Joste, Nancy et al. (2010) Anti-IgE therapy results in decreased myeloid dendritic cells in asthmatic airways. J Allergy Clin Immunol 125:1157-1158.e5
Lipscomb, Mary F; Hutt, Julie; Lovchik, Julie et al. (2010) The pathogenesis of acute pulmonary viral and bacterial infections: investigations in animal models. Annu Rev Pathol 5:223-52
Borovkov, Alex Y; Loskutov, Andrey V; Robida, Mark D et al. (2010) High-quality gene assembly directly from unpurified mixtures of microarray-synthesized oligonucleotides. Nucleic Acids Res 38:e180
Collazo, Carmen M; Meierovics, Anda I; De Pascalis, Roberto et al. (2009) T cells from lungs and livers of Francisella tularensis-immune mice control the growth of intracellular bacteria. Infect Immun 77:2010-21
Wu, Terry H; Zsemlye, Jason L; Statom, Gloria L et al. (2009) Vaccination of Fischer 344 rats against pulmonary infections by Francisella tularensis type A strains. Vaccine 27:4684-93
Hahn, Andrew C; Lyons, C Rick; Lipscomb, Mary F (2008) Effect of Bacillus anthracis virulence factors on human dendritic cell activation. Hum Immunol 69:552-61

Showing the most recent 10 out of 12 publications